Wilfried Seifert

921 total citations
24 papers, 628 citations indexed

About

Wilfried Seifert is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Wilfried Seifert has authored 24 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Wilfried Seifert's work include Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Wilfried Seifert is often cited by papers focused on Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Wilfried Seifert collaborates with scholars based in Germany, United States and Italy. Wilfried Seifert's co-authors include A. Bosma, Dick Knook, Mirjam Mol-Arts, Peter Kenemans, Steven R. Cummings, Bruce Ettinger, Paul E. Verweij, Susan R. Johnson, Eduardo Kerzberg and Pierre D. Delmas and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Wilfried Seifert

22 papers receiving 597 citations

Peers

Countries citing papers authored by Wilfried Seifert

Since Specialization

Citations

This map shows the geographic impact of Wilfried Seifert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilfried Seifert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilfried Seifert more than expected).

Fields of papers citing papers by Wilfried Seifert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilfried Seifert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilfried Seifert. The network helps show where Wilfried Seifert may publish in the future.

Co-authorship network of co-authors of Wilfried Seifert

This figure shows the co-authorship network connecting the top 25 collaborators of Wilfried Seifert. A scholar is included among the top collaborators of Wilfried Seifert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilfried Seifert. Wilfried Seifert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extension Study With rVIII‐SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A 2025 ·Haemophilia ·Johnny Mahlangu, Maria Elisa Mancuso, Kathelijn Fischer, Claudia Djambas Khayat, Manuela Carvalho, Faraizah Abdul Karim, Shawn M. Jobe, (unknown), (unknown), (unknown), Brahm Goldstein, Wilfried Seifert, (unknown), Christoph Königs	0
2	Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review 2024 ·Haemophilia ·Cihan Ay, Mariasanta Napolitano, (unknown), (unknown), (unknown), Wilfried Seifert, (unknown), Johannes Oldenburg	2
3	Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX‐FP in the PROLONG‐9FP clinical trial program 2023 ·European Journal Of Haematology ·(unknown), Katsuyuki Fukutake, María Fernanda López Fernández, Yanyan Li, Wilfried Seifert, Annarita Tagliaferri	1
4	Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients 2023 ·Research and Practice in Thrombosis and Haemostasis ·Ingrid Pabinger, Toshko Lissitchkov, (unknown), (unknown), Yanyan Li, Wilfried Seifert, Maria Elisa Mancuso	2
5	Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients 2021 ·Journal of Blood Medicine ·Claudia Djambas Khayat, Genadi Iosava, (unknown), Oleksandra Stasyshyn, (unknown), (unknown), Tobias Rogosch, Wilfried Seifert	1
6	<p>An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study)</p> 2020 ·Journal of Blood Medicine ·Toshko Lissitchkov, Anna Klukowska, (unknown), (unknown), G. Auerswald, Oleksandra Stasyshyn, Wilfried Seifert, Tobias Rogosch	4
7	High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice 2020 ·Haemophilia ·Maria Elisa Mancuso, Johannes Oldenburg, Lisa Boggio, Gili Kenet, Anthony K.C. Chan, Carmen Altisent, Wilfried Seifert, Elena Santagostino	12
8	<p>Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)</p> 2020 ·Journal of Blood Medicine ·G. Auerswald, Claudia Djambas Khayat, Oleksandra Stasyshyn, Genadi Iosava, (unknown), (unknown), Wilfried Seifert, Tobias Rogosch	6
9	Simplifying surgery in haemophilia B: Low factor IX consumption and infrequent infusions in surgical procedures with rIX-FP 2020 ·Thrombosis Research ·Julie Curtin, Elena Santagostino, Faraizah Abdul Karim, Yanyan Li, Wilfried Seifert, Claude Négrier	7
10	Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study 2020 ·Thrombosis and Haemostasis ·Gili Kenet, Hérvè Chambost, Christoph Male, Susan Halimeh, Thierry Lambert, Yanyan Li, Wilfried Seifert, Elena Santagostino	15
11	Health‐related quality of life in paediatric haemophilia B patients treated with rIX‐FP 2018 ·Haemophilia ·Sylvia von Mackensen, (unknown), Wilfried Seifert, Gili Kenet	25
12	Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study) 2016 ·Blood Coagulation & Fibrinolysis ·Toshko Lissitchkov, (unknown), Kazimierz Kuliczkowski, Oleksandra Stasyshyn, M. Cerqueira, Anna Klukowska, (unknown), Wilfried Seifert	13
13	Efficacy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (VONCENTO®) in subjects with haemophilia A (SWIFT-HA study) 2015 ·Thrombosis Research ·Aleksander B. Skotnicki, Toshko Lissitchkov, Vasily Mamonov, (unknown), Kazimierz Kuliczkowski, Vesselina Goranova‐Marinova, Janusz Kłoczko, Anna Klukowska, (unknown), Liana Gercheva, Tatiana A. Chernova, Andrzej Hellmann, Anna Dmoszyńska, Krystyna Zawilska, Alex Veldman, (unknown), Wilfried Seifert	6
14	Endometrial Effects of Tibolone in Elderly, Osteoporotic Women 2008 ·Obstetrics and Gynecology ·Bruce Ettinger, Peter Kenemans, Susan R. Johnson, Mirjam Mol-Arts, Steve van Os, Wilfried Seifert, Paul E. Verweij, Steven R. Cummings	17
15	The Effects of Tibolone in Older Postmenopausal Women 2008 ·New England Journal of Medicine ·Steven R. Cummings, Bruce Ettinger, Pierre D. Delmas, Peter Kenemans, V. M. Stathopoulos, Paul E. Verweij, Mirjam Mol-Arts, (unknown), Lori Mosca, Claus Christiansen, (unknown), Eduardo Kerzberg, Susan R. Johnson, José Zanchetta, (unknown), Wilfried Seifert, Richard Eastell	292
16	Intraoperative irradiation delays anastomotic repair in rat colon 1995 ·The American Journal of Surgery ·Wilfried Seifert, Theo Wobbes, Jaap Hoogenhout, Ben M. de Man, (unknown), (unknown)	23
17	Alcohol in combination with malnutrition causes increased liver fibrosis in rats 1994 ·Journal of Hepatology ·A. Bosma, Wilfried Seifert, (unknown), Rick E.W. van Leeuwen, Bep Blauw, Paul Roholl, Dick Knook, Adriaan Brouwer	19
18	Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis 1988 ·The Journal of Pathology ·A. Bosma, Adriaan Brouwer, Wilfried Seifert, Dick Knook	41
19	Catecholamines and endogeneous opioids in ventral tegmental self-stimulation reward 1988 ·Pharmacology Biochemistry and Behavior ·Leo van Wolfswinkel, Wilfried Seifert, Jan M. van Ree	17
20	Long-term changes in self-stimulation threshold by repeated morphine and naloxone treatment 1985 ·Life Sciences ·Leo van Wolfswinkel, Wilfried Seifert, Jan M. van Ree	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact